ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +6 | 1.07B | $270.09B | +9 | −2 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | — | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | — |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | — | — |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | — | — |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | — | 90.79M | $15.55B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 36.68M | — | $6.28B | 0.6% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 36.68M | — | $6.28B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (pasivo) | 22.48M | — | $3.86B | 0.6% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 10.94M | — | $1.88B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 10.94M | — | $1.88B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Capital World Investors ✦ | 10.28M | — | $1.76B | 0.3% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 2.88M | — | $494.42M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 1.42M | — | $243.61M | 0.5% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.40M | — | $237.81M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.40M | — | $237.81M | 0.4% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 1.40M | — | $237.81M | 0.4% | n/c | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 1.30M | — | $223.78M | 0.4% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 980.23K | — | $168.13M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 918.63K | — | $157.56M | 0.2% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 918.63K | — | $157.56M | 0.2% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 885.91K | — | $151.95M | 0.2% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 288.52K | — | $49.49M | 0.3% | n/c | 1 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 183.07K | — | $31.40M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 46.08K | — | $7.90M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 39.80K | — | $6.83M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 17.07K | — | $2.93M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | GAMCO Investors ✦ | 14.75K | — | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Dodge & Cox ✦ | 11.01K | — | $1.89M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Harris Associates (Oakmark) ✦ | 1.49K | — | $256,079 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 82.20K acciones, $17,877 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 32.71K acc. · $8.18M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología